Systematic Analysis of Quantitative Logic Model Ensembles Predicts Drug Combination Effects on Cell Signaling Networks

Abstract

A major challenge in developing anticancer therapies is determining the efficacies of drugs and their combinations in physiologically relevant microenvironments. We describe here our application of constrained fuzzy logic (CFL) ensemble modeling of the intracellular signaling network for predicting inhibitor treatments that reduce the phospho-levels of key transcription factors downstream of growth factors and inflammatory cytokines representative of hepatocellular carcinoma (HCC) microenvironments. We observed that the CFL models successfully predicted the effects of several kinase inhibitor combinations. Furthermore, the ensemble predictions revealed ambiguous predictions that could be traced to a specific structural feature of these models, which we resolved with dedicated experiments, finding that IL-1a activates downstream signals through TAK1 and not MEKK1 in HepG2 cells. We conclude that CFL-Q2LM (Querying Quantitative Logic Models) is a promising approach for predicting effective anticancer drug combinations in cancer-relevant microenvironments.

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Aug 27, 2016
Accession Number
AD1052937

Entities

People

  • D. A. Lauffenburger
  • D. C. Clarke
  • L. C. Osimiri
  • M. K. Morris

Organizations

  • Massachusetts Institute of Technology

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Bioengineering
  • Biological Factors
  • Cell Physiological Processes
  • Cells
  • Chemistry
  • Drug Combinations
  • Experimental Data
  • Fuzzy Logic
  • Gene Expression
  • Growth Factors
  • Peptide Growth Factors
  • Peptides
  • Proteins
  • Proteomics
  • Small Molecules
  • Therapy
  • Transcription Factors

Fields of Study

  • Biology

Readers

  • Cellular and Molecular Pathways of Apoptosis.
  • Computational Modeling and Simulation
  • Immunology and Pathology